16 March 2026
Pure Global: Brazil's AI Gambit - Decoding CFM's Unwritten MedTech Rules.
LATAM MedTech Insights
About
Brazil just added a complex new layer to its AI MedTech regulations. Last week, the Federal Council of Medicine (CFM) issued Resolution 2,454, a framework that directly impacts how physicians can use AI tools. This isn't about device registration through ANVISA; it's about winning the trust and acceptance of the end-users—the doctors themselves.
This episode dives deep into what this resolution means for foreign MedTech innovators. We explore how this new ethical and governance-focused oversight creates a dual-approval landscape where both regulatory bodies and medical associations hold the keys to market access. We break down the unwritten rules and hidden challenges that your company will now face in Latin America's largest market.
Imagine your AI-powered diagnostic software, already successful in Europe, is being trialed in a major São Paulo hospital. Suddenly, the clinical lead halts the trial. The reason? Your firm can't produce a satisfactory governance report detailing how the AI's algorithms align with the CFM's new ethical guidelines, creating a market-access roadblock that no one saw coming.
In this episode, you will learn:
- What are the crucial differences between ANVISA's requirements and the CFM's new AI resolution?
- Why might your international clinical data be insufficient to gain physician trust in Brazil?
- How does a doctor's new "right of refusal" for AI tools change your market entry strategy?
- Is this new resolution a hidden barrier or an opportunity to build a stronger competitive moat?
- What kind of local data and governance documentation do you now need to prepare?
- How can you proactively engage with Brazil's medical community to ensure adoption?
- What are the three key steps to de-risk your AI MedTech launch in this new environment?
Struggling to keep up with shifting regulations in LATAM? At Pure Global, we offer end-to-end regulatory consulting for MedTech and IVD companies, leveraging local expertise and advanced AI tools to streamline your market access. From acting as your local representative in Brazil to compiling technical dossiers with our AI platform, we turn regulatory hurdles into market opportunities. Don't let compliance challenges slow your growth. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to secure your foothold in Latin America.
This episode dives deep into what this resolution means for foreign MedTech innovators. We explore how this new ethical and governance-focused oversight creates a dual-approval landscape where both regulatory bodies and medical associations hold the keys to market access. We break down the unwritten rules and hidden challenges that your company will now face in Latin America's largest market.
Imagine your AI-powered diagnostic software, already successful in Europe, is being trialed in a major São Paulo hospital. Suddenly, the clinical lead halts the trial. The reason? Your firm can't produce a satisfactory governance report detailing how the AI's algorithms align with the CFM's new ethical guidelines, creating a market-access roadblock that no one saw coming.
In this episode, you will learn:
- What are the crucial differences between ANVISA's requirements and the CFM's new AI resolution?
- Why might your international clinical data be insufficient to gain physician trust in Brazil?
- How does a doctor's new "right of refusal" for AI tools change your market entry strategy?
- Is this new resolution a hidden barrier or an opportunity to build a stronger competitive moat?
- What kind of local data and governance documentation do you now need to prepare?
- How can you proactively engage with Brazil's medical community to ensure adoption?
- What are the three key steps to de-risk your AI MedTech launch in this new environment?
Struggling to keep up with shifting regulations in LATAM? At Pure Global, we offer end-to-end regulatory consulting for MedTech and IVD companies, leveraging local expertise and advanced AI tools to streamline your market access. From acting as your local representative in Brazil to compiling technical dossiers with our AI platform, we turn regulatory hurdles into market opportunities. Don't let compliance challenges slow your growth. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to secure your foothold in Latin America.